As of November 2024, Clinuvel Pharmaceuticals has a market cap of $500.75M. This makes Clinuvel Pharmaceuticals the world's 11332th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $527.83M | -1.31% |
2023 | $534.85M | -26.17% |
2022 | $724.38M | -20.36% |
2021 | $909.57M | 21.91% |
2020 | $746.11M | -21.55% |
2019 | $951.02M | 57.18% |
2018 | $605.04M | 121.00% |
2017 | $273.77M | 9.93% |
2016 | $249.04M | 183.27% |
2015 | $87.92M | -37.38% |
2014 | $140.40M | 342.11% |
2013 | $31.76M | -48.09% |
2012 | $61.17M | 17.31% |
2011 | $52.15M | -24.64% |
2010 | $69.20M | -23.33% |
2009 | $90.26M | 12.50% |
2008 | $80.23M | -30.43% |
2007 | $115.33M | -52.41% |
2006 | $242.35M | 122.89% |
2005 | $108.73M | -63.04% |
2004 | $294.22M | 37.31% |
2003 | $214.27M | 415.38% |
2002 | $41.57M | -48.00% |
2001 | $79.95M | - |